Mytrex Health Technologies, Inc.
Mytrex Health Technologies, Inc. engages in the manufacturing, processing, and sale of various filter non-woven fabrics in Taiwan, rest of Asia, Europe, and internationally. The company provides electrostatic filtration materials for medical and industrial mask media, and other filtration applications; and composite nonwoven products for coolant and air filter, vacuum filter bag, HEPA and cabin f… Read more
Mytrex Health Technologies, Inc. (4431) - Total Assets
Latest total assets as of June 2025: NT$1.14 Billion TWD
Based on the latest financial reports, Mytrex Health Technologies, Inc. (4431) holds total assets worth NT$1.14 Billion TWD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Mytrex Health Technologies, Inc. - Total Assets Trend (2019–2024)
This chart illustrates how Mytrex Health Technologies, Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Mytrex Health Technologies, Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Mytrex Health Technologies, Inc.'s total assets of NT$1.14 Billion consist of 60.4% current assets and 39.6% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 24.0% |
| Accounts Receivable | NT$191.03 Million | 16.7% |
| Inventory | NT$200.96 Million | 17.5% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$70.82 Million | 6.2% |
| Goodwill | NT$12.99 Million | 1.1% |
Asset Composition Trend (2019–2024)
This chart illustrates how Mytrex Health Technologies, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Mytrex Health Technologies, Inc.'s current assets represent 60.4% of total assets in 2024, a decrease from 68.8% in 2019.
- Cash Position: Cash and equivalents constituted 24.0% of total assets in 2024, down from 36.9% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 17.5% of total assets.
Mytrex Health Technologies, Inc. Competitors by Total Assets
Key competitors of Mytrex Health Technologies, Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hanil Vacuum Co. Ltd
KQ:123840
|
Korea | ₩115.98 Billion |
|
Ivisionworks Co.,Ltd.
KQ:469750
|
Korea | ₩50.10 Billion |
|
Huayi Compressor Co Ltd
SHE:000404
|
China | CN¥15.16 Billion |
|
Shenyang Machine Tool Co Ltd
SHE:000410
|
China | CN¥9.63 Billion |
|
North Industries Group Red Arrow Co Ltd
SHE:000519
|
China | CN¥17.38 Billion |
|
Changchai Co Ltd
SHE:000570
|
China | CN¥5.30 Billion |
|
Jiangsu Youli Investment Holding Co Ltd
SHE:000584
|
China | CN¥3.49 Billion |
|
Baota Industry Co Ltd
SHE:000595
|
China | CN¥9.54 Billion |
Mytrex Health Technologies, Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Mytrex Health Technologies, Inc. generates 1.54x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Mytrex Health Technologies, Inc. is currently not profitable relative to its asset base.
Mytrex Health Technologies, Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.69 | 1.58 | 3.38 |
| Quick Ratio | 1.17 | 1.19 | 3.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$291.10 Million | NT$ 313.47 Million | NT$ 450.69 Million |
Mytrex Health Technologies, Inc. - Advanced Valuation Insights
This section examines the relationship between Mytrex Health Technologies, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.12 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -8.9% |
| Total Assets | NT$1.15 Billion |
| Market Capitalization | $7.76 Million USD |
Valuation Analysis
Below Book Valuation: The market values Mytrex Health Technologies, Inc.'s assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Mytrex Health Technologies, Inc.'s assets decreased by 8.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Mytrex Health Technologies, Inc. (2019–2024)
The table below shows the annual total assets of Mytrex Health Technologies, Inc. from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$1.15 Billion | -8.94% |
| 2023-12-31 | NT$1.26 Billion | -15.45% |
| 2022-12-31 | NT$1.49 Billion | +55.96% |
| 2021-12-31 | NT$954.12 Million | -28.04% |
| 2020-12-31 | NT$1.33 Billion | +225.86% |
| 2019-12-31 | NT$406.87 Million | -- |